There are several limitations to the CMS negotiation approach illustrated in this example, starting with the dubious implicit assumption that the prices for therapeutic alternatives will be fair. Once ...

For example, a MFP set at the drug’s recent net price (ceiling) would suggest no direct net savings for Medicare, but beneficiaries may experience reductions in their out-of-pocket payments as the MFP ...